Author's posts
AstraZeneca’s Covid-19 Antibody Therapy Effective In Preventing Symptoms Among High-Risk Groups, Trial Finds
AstraZeneca’s treatment may offer additional protection to vulnerable groups who fail to generate a strong immune response through vaccines.
New Zealand Extends Nationwide Lockdown As Delta Variant Outbreak Grows
New Zealand Prime Minister Jacinda Ardern warned that the full extent of the current delta variant outbreak is unknown.
U.S. Set To Recommend Booster Covid-19 Vaccine Dose For Most People, Reports Say
Americans across all age groups will reportedly be advised to take a booster shot eight months after they received their second dose, to ensure lasting protection.
U.K. Variant Of Coronavirus Doesn’t Cause More Severe Covid-19 Cases, Study Finds
The study contradicts several others published last month that suggested the U.K. variant was associated with an increased risk of death.
Revised U.S. Trials Numbers Show AstraZeneca Vaccine Is 76% Effective Against Symptomatic Covid-19
The new result reiterates the vaccine is 100% effective in preventing severe disease and hospitalization.
AstraZeneca May Have Included ‘Outdated Information’ In U.S. Trial Results, NIAID Says
The U.S. government agency has urged AstraZeneca to review the efficacy data and ensure the most accurate, up-to-date data is made public.
AstraZeneca Vaccine Helps Slow Covid-19 Transmission, First Dose 76% Effective For At Least Three Months, Study Finds
A second dose of the Oxford-AstraZeneca vaccine raises the vaccine’s efficacy to 82.4% if it is administered after a 12-week gap.
Johnson & Johnson’s Single-Dose Covid-19 Vaccine Is 66% Effective In Global Trial, But Has Lower Efficacy Against South African Variant
In the U.S. the vaccine had an effectiveness of 72% but that number dropped to just 57% in South Africa where a more infectious variant of the virus is spreading.
Moderna Launches Trial For Covid-19 Vaccine Booster To Tackle South African Strain
Moderna’s vaccine works well against the more transmissible U.K. strain but the neutralizing antibody response was found to be lower against the newly discovered South African variant.
U.K., India May Approve Cheaper Oxford-AstraZeneca Covid-19 Vaccine As Soon As Next Week
The AstraZeneca vaccine is easier and cheaper to manufacture, store and transport.
